Abstract

INTRODUCTIONTo achieve the Sustainable Development Goals (SDGs) target 2030, the United Nations (UN) endorsed tobacco use reduction, which is essential in decreasing unnecessary deaths caused by tobacco-induced disease. This study investigates the association between tobacco use and Human Papillomavirus (HPV) infection in clinically normal uterine cervix populations from the SDGs perspective.METHODSThis study is a 7-year cross-sectional study of a clinically normal uterine cervix population, based on negative Visual Inspection of Acetic Acid (VIA). Subjects were recruited consecutively from the medical records of several public and private health providers in Jakarta. The Statistical Product and Service Solutions (SPSS) for Windows version 20.0 were used to analyze the data.RESULTSA total of 1397 negative VIA subjects were collected, consisting of 4.9% (69/1397) tobacco users, and 95.1% (1328/1397) non-users. HPV-DNA positive were 4.3% (3/69) in the tobacco user group and 3.7% (49/1328) in the non-user group. Statistical analysis showed unadjusted OR was 1.19 (95% CI: 0.36–3.91, p=0.778) and adjusted OR was 1.18 (95% CI: 0.36–3.89, p=0.786). High-risk HPV (hrHPV) infections of tobacco and non-tobacco users’ groups were found in 2/3 and 27/49 (55.1%), respectively.CONCLUSIONSThis study showed an insignificant statistical association between tobacco use and HPV infection in normal uterine cervix. However, the proportion of hrHPV infection was higher in tobacco users than non-users. From the SDGs perspective, cervical cancer is closely related to tobacco use and poverty. Further study is needed to support this result and evaluate other co-factor role-related cervical cancer history to achieve SDGs in 2030.

Highlights

  • INTRODUCTION To achieve the Sustainable DevelopmentGoals (SDGs) target 2030, the United Nations (UN) endorsed tobacco use reduction, which is essential in decreasing unnecessary deaths caused by tobacco-induced disease

  • This study aimed to discover the association between tobacco use and Human Papillomavirus (HPV) infection in normal uterine cervix from the SDGs perspective

  • This study found that 2 of 3 tobacco users with positive HPV DNA were infected with HPV 16 or 18 as the predominant High-risk HPV (hrHPV) group

Read more

Summary

Introduction

INTRODUCTION To achieve the Sustainable DevelopmentGoals (SDGs) target 2030, the United Nations (UN) endorsed tobacco use reduction, which is essential in decreasing unnecessary deaths caused by tobacco-induced disease. This study investigates the association between tobacco use and Human Papillomavirus (HPV) infection in clinically normal uterine cervix populations from the SDGs perspective. A collaborative reanalysis of 12 studies supported that current tobacco smoking was associated with an increased risk of squamous cell carcinoma (SCC), but not adenocarcinoma (AC)[2,3,4,5]. Understanding the history of HPV infection in the uterine cervix enables mapping out strategies to prevent cervical cancer[9]. Increasing the number of HPV infections has been associated with tobacco use. Tobacco can affect the replication of HPV-DNA and accelerate the HPV life cycle. As a consequence, it can increase the ability of the virus to damage the cervical epithelium. The most active smokers are men, women contribute, especially as passive smokers, resulting in the same negative effects of smoking[15]

Objectives
Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call